134 related articles for article (PubMed ID: 27371652)
1. Severe Rheumatoid Arthritis Developing in Conjunction with Gorlin Syndrome.
Scott JF; Bordeaux JS
J Rheumatol; 2016 Jul; 43(7):1447-9. PubMed ID: 27371652
[No Abstract] [Full Text] [Related]
2. 9q22.3 Microdeletion Syndrome with Multiple Basal Cell Carcinomas Treated with Vismodegib: Three Key Messages in One Patient.
Kieny A; Kremer V; Scheidecker S; Lipsker D
Acta Derm Venereol; 2018 Feb; 98(2):287-288. PubMed ID: 29057423
[No Abstract] [Full Text] [Related]
3. Surgical excision after neoadjuvant therapy with vismodegib for a locally advanced basal cell carcinoma and resistant basal carcinomas in Gorlin syndrome.
Chang AL; Atwood SX; Tartar DM; Oro AE
JAMA Dermatol; 2013 May; 149(5):639-41. PubMed ID: 23677114
[No Abstract] [Full Text] [Related]
4. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.
Wolfe CM; Green WH; Cognetta AB; Hatfield HK
Dermatol Surg; 2012 Nov; 38(11):1863-6. PubMed ID: 22805146
[No Abstract] [Full Text] [Related]
5. Patient with Gorlin syndrome and metastatic basal cell carcinoma refractory to smoothened inhibitors.
Zhu GA; Li AS; Chang AL
JAMA Dermatol; 2014 Aug; 150(8):877-9. PubMed ID: 24898076
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of Drug Resistance in Basal Cell Nevus Syndrome Tumors through Basal to Squamous Cell Carcinoma Transition.
Jussila AR; Haensel D; Gaddam S; Oro AE
J Invest Dermatol; 2024 Jun; 144(6):1368-1377.e6. PubMed ID: 38157930
[TBL] [Abstract][Full Text] [Related]
7. Unexpected manifestation of naevoid basal cell carcinoma (Gorlin) syndrome with a novel mutation in the PTCH1 gene in a female patient with long-lasting pemphigus vulgaris.
Goetze S; Raessler F; Hipler UC; Schulz S; Kohlhase J; Elsner P
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):493-4. PubMed ID: 25600101
[No Abstract] [Full Text] [Related]
8. Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.
Tang JY
Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S6-9. PubMed ID: 22177103
[TBL] [Abstract][Full Text] [Related]
9. Comment on basal cell carcinoma rebound after cessation of vismodegib in an individual with basal cell nevus syndrome.
Ally MS; Wysong A; Tang JY; Aasi S
Dermatol Surg; 2013 Sep; 39(9):1413-4. PubMed ID: 23682843
[No Abstract] [Full Text] [Related]
10. [Not Available].
Basset-Seguin N
Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS36-VS41. PubMed ID: 30477683
[TBL] [Abstract][Full Text] [Related]
11. Enlarging Multiple Neoplastic Skin Growths.
Feinstein EG; Zhou M; Setabutr P
JAMA Ophthalmol; 2016 Mar; 134(3):337-8. PubMed ID: 26767432
[No Abstract] [Full Text] [Related]
12. Vismodegib in advanced basal-cell carcinoma.
Henkin RI
N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
[No Abstract] [Full Text] [Related]
13. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
Lear JT
N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
[No Abstract] [Full Text] [Related]
14. Intermittent Vismodegib Therapy in Basal Cell Nevus Syndrome.
Yang X; Dinehart SM
JAMA Dermatol; 2016 Feb; 152(2):223-4. PubMed ID: 26509945
[No Abstract] [Full Text] [Related]
15. Effect of Calcium Channel Blockade on Vismodegib-Induced Muscle Cramps.
Ally MS; Tang JY; Lindgren J; Acosta-Raphael M; Rezaee M; Chanana AM; Epstein EH
JAMA Dermatol; 2015 Oct; 151(10):1132-4. PubMed ID: 26200175
[No Abstract] [Full Text] [Related]
16. Gorlin Syndrome, Vulvar Basal Cell Carcinomas, Vismodegib, and Lichen Sclerosus: From the ISSVD Case Consultation Committee.
Kirkpatrick E; Dobriansky D; Scurry J
J Low Genit Tract Dis; 2016 Jul; 20(3):e40-1. PubMed ID: 27105331
[No Abstract] [Full Text] [Related]
17. [A new drug for basal cell carcinoma].
Witte F
Schweiz Monatsschr Zahnmed; 2013; 123(12):1104-6. PubMed ID: 24730087
[No Abstract] [Full Text] [Related]
18. Mesenteric cysts in naevoid basal cell carcinoma syndrome: a mimic of metastatic disease.
Rajan N; Brown S; Ward S; Hainsworth P; Hodgkinson P; Pieniazek P; Husain A; Plummer R
Br J Dermatol; 2016 Mar; 174(3):684-5. PubMed ID: 26473628
[No Abstract] [Full Text] [Related]
19. Histologic changes in basal cell carcinoma after treatment with vismodegib.
Aldabagh B; Yu J; Perkocha LA; Arron S
Dermatol Surg; 2013 Nov; 39(11):1703-5. PubMed ID: 23879864
[No Abstract] [Full Text] [Related]
20. Targeting the hedgehog pathway to treat basal cell carcinoma.
Geeraert P; Williams JS; Brownell I
J Drugs Dermatol; 2013 May; 12(5):519-23. PubMed ID: 23652945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]